Trial record 1 of 1 for:    MM08-141
Previous Study | Return to List | Next Study

Bendamustine in Combination With Bortezomib and Pegylated Liposomal Doxorubicin for Multiple Myeloma

This study is currently recruiting participants.
Verified February 2014 by Hoosier Oncology Group
Sponsor:
Collaborator:
Cephalon
Information provided by (Responsible Party):
Hoosier Oncology Group
ClinicalTrials.gov Identifier:
NCT01177683
First received: August 5, 2010
Last updated: February 12, 2014
Last verified: February 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2015
  Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)